Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has granted equity awards to four newly hired employees, the company announced on November 20, 2024. These awards, given as part of the …
Savara Inc. Announces Stock Awards for New Employees Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has released its financial results for the third quarter ending September 30, 2024, and provided an important business update that underscores the company’s …
Savara Inc. Reports Third-Quarter Financial Results and Announces Key Regulatory Milestones Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) recently featured in a new episode of The Balancing Act® on Lifetime TV, focusing on autoimmune Pulmonary Alveolar Proteinosis (aPAP). This episode, part …
Savara Inc. Shines Spotlight on Rare Lung Disease in New TV Feature Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a biopharmaceutical company, has announced the distribution of inducement awards to four new employees as part of their compensation package. These awards, granted on …
Savara Inc. Rewards New Employees with Inducement Awards Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the approval of inducement awards to Braden Parker, who recently joined the company as Chief Commercial Officer on September 24, 2024. These …
Savara Inc. Grants Inducement Awards to New Chief Commercial Officer Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has unveiled the Savara Early Access Program, a significant initiative aimed at providing molgramostim to patients suffering from autoimmune pulmonary alveolar proteinosis (aPAP). This …
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the appointment of Braden Parker as Chief Commercial Officer, effective immediately. Parker brings over 25 years of experience in the healthcare and …
Savara Inc. Appoints Braden Parker as Chief Commercial Officer Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the issuance of inducement awards to a new team member, aligning with the company’s strategic growth initiatives.
Savara Inc. Grants Inducement Awards to New Employee Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s progress in clinical …
Savara Inc. Reports Strong Q2 2024 Results and Positive IMPALA-2 Trial Outcomes Read More
LANGHORNE, PA — In a significant advancement for patients suffering from autoimmune Pulmonary Alveolar Proteinosis (aPAP), Savara Inc. has revealed promising outcomes from its IMPALA-2 Phase 3 clinical trial. The …
Savara Inc. Announces Breakthrough in aPAP Treatment with IMPALA-2 Trial Success Read More